5.60
price up icon3.53%   0.22
 
loading
Schlusskurs vom Vortag:
$5.38
Offen:
$5.38
24-Stunden-Volumen:
232.60K
Relative Volume:
0.32
Marktkapitalisierung:
$722.01M
Einnahmen:
$58.49M
Nettoeinkommen (Verlust:
$-105.04M
KGV:
-4.3087
EPS:
-1.2997
Netto-Cashflow:
$-13.78M
1W Leistung:
+2.39%
1M Leistung:
+3.34%
6M Leistung:
-21.66%
1J Leistung:
-53.58%
1-Tages-Spanne:
Value
$5.2701
$5.60
1-Wochen-Bereich:
Value
$5.23
$5.71
52-Wochen-Spanne:
Value
$3.30
$13.09

Immatics N V Stock (IMTX) Company Profile

Name
Firmenname
Immatics N V
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
423
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-26
Name
Neueste SEC-Einreichungen
Name
IMTX's Discussions on Twitter

Vergleichen Sie IMTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IMTX
Immatics N V
5.59 722.01M 58.49M -105.04M -13.78M -1.2997
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.75 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.09 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.57 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
555.67 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
246.00 28.51B 3.81B -644.79M -669.77M -6.24

Immatics N V Stock (IMTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-28 Eingeleitet Deutsche Bank Buy
2024-10-07 Eingeleitet Piper Sandler Overweight
2023-11-02 Eingeleitet Cantor Fitzgerald Overweight
2023-03-31 Eingeleitet Mizuho Buy
2023-03-24 Eingeleitet Bryan Garnier Buy
2020-11-20 Eingeleitet BofA Securities Buy
2020-09-22 Eingeleitet Goldman Buy
2020-07-27 Eingeleitet SVB Leerink Outperform
2020-07-24 Eingeleitet Jefferies Buy
Alle ansehen

Immatics N V Aktie (IMTX) Neueste Nachrichten

pulisher
Jun 18, 2025

Immatics N.V. Shareholders Approve Key Resolutions at June 2025 AGM - TipRanks

Jun 18, 2025
pulisher
Jun 17, 2025

These Numbers Reveal How Powerful Immatics N.V (NASDAQ: IMTX) Stock Is - Stocksregister

Jun 17, 2025
pulisher
Jun 11, 2025

Learn to Evaluate (IMTX) using the Charts - news.stocktradersdaily.com

Jun 11, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Comments on Immatics FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Two Sigma Investments LP Sells 36,345 Shares of Immatics (NASDAQ:IMTX) - Defense World

Jun 10, 2025
pulisher
Jun 08, 2025

Immatics (NASDAQ:IMTX) Shares Sold by Two Sigma Advisers LP - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME - Revista ADVFN

Jun 05, 2025
pulisher
Jun 05, 2025

Immatics rises on data from early stage cell therapy trial - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Millennium Management LLC Has $1.11 Million Holdings in Immatics (NASDAQ:IMTX) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Immatics: Taking Off On A PRAME Rocketship - Seeking Alpha

Jun 04, 2025
pulisher
Jun 03, 2025

Does Immatics (IMTX) Have the Potential to Rally 174.54% as Wall Street Analysts Expect? - Yahoo Finance

Jun 03, 2025
pulisher
Jun 03, 2025

Immatics Announces Annual General Meeting for June 2025 - TipRanks

Jun 03, 2025
pulisher
Jun 02, 2025

immatics n.v. announces upcoming annual general meeting By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

immatics n.v. announces upcoming annual general meeting - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Immatics (IMTX) Soars After Positive Trial Results for Cell Ther - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Cantor Fitzgerald reiterates overweight rating on Immatics stock By Investing.com - Investing.com UK

Jun 02, 2025
pulisher
Jun 02, 2025

Immatics Presents Promising IMA203 Data at ASCO 2025 - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Form 6-K Immatics N.V. For: Jun 02 - StreetInsider

Jun 02, 2025
pulisher
Jun 02, 2025

Northern Trust Corp Purchases 11,304 Shares of Immatics (NASDAQ:IMTX) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Immatics (IMTX) Shares Promising Data from IMA203 Melanoma Trials | IMTX Stock News - GuruFocus

Jun 01, 2025
pulisher
May 31, 2025

Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 - GlobeNewswire

May 31, 2025
pulisher
May 31, 2025

Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO - GuruFocus

May 31, 2025
pulisher
May 31, 2025

Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma | IMTX Stock News - GuruFocus

May 31, 2025
pulisher
May 31, 2025

Immatics N.V. Reports Promising Long-Term Efficacy and Safety Data from Phase 1b Trial of IMA203 PRAME Cell Therapy in Metastatic Melanoma - Nasdaq

May 31, 2025
pulisher
May 31, 2025

PRAME Cell Therapy Shows 56% Response Rate in Melanoma Patients at ASCO 2025 | IMTX Stock News - Stock Titan

May 31, 2025
pulisher
May 31, 2025

Immatics (NASDAQ:IMTX) Receives $17.00 Average Price Target from Analysts - Defense World

May 31, 2025
pulisher
May 30, 2025

Immatics N.V. (IMTX) Stock Analysis: Uncovering a 163% Upside Potential in the Biotech Arena - DirectorsTalk Interviews

May 30, 2025
pulisher
May 29, 2025

Long Term Trading Analysis for (IMTX) - news.stocktradersdaily.com

May 29, 2025
pulisher
May 29, 2025

Immatics (NASDAQ:IMTX) Coverage Initiated by Analysts at Deutsche Bank Aktiengesellschaft - Defense World

May 29, 2025
pulisher
May 29, 2025

D. E. Shaw & Co. Inc. Has $176,000 Stake in Immatics (NASDAQ:IMTX) - Defense World

May 29, 2025
pulisher
May 28, 2025

Deutsche Bank Initiates Coverage of Immatics N.V. (IMTX) with Buy Recommendation - Nasdaq

May 28, 2025
pulisher
May 28, 2025

Immatics (IMTX) Receives "Buy" Rating from Deutsche Bank | IMTX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Deutsche Bank Initiates Coverage on Immatics With Buy Rating, $10 Price Target - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Deutsche Bank Gives Immatics (IMTX) a Boost with Buy Rating and $10 Target | IMTX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Deutsche Bank sets $10 target for Immatics stock on Buy rating - Investing.com UK

May 28, 2025
pulisher
May 18, 2025

Immatics FY2025 EPS Forecast Increased by Cantor Fitzgerald - Defense World

May 18, 2025
pulisher
May 17, 2025

Lacklustre Performance Is Driving Immatics N.V.'s (NASDAQ:IMTX) Low P/S - simplywall.st

May 17, 2025
pulisher
May 16, 2025

The Manufacturers Life Insurance Company Sells 71,487 Shares of Immatics (NASDAQ:IMTX) - Defense World

May 16, 2025
pulisher
May 15, 2025

We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash Wisely - Yahoo Finance

May 15, 2025
pulisher
May 14, 2025

Immatics: Q1 Earnings Snapshot - CT Insider

May 14, 2025
pulisher
May 14, 2025

Immatics Announces First Quarter 2025 Financial Results and Business Update - GlobeNewswire

May 14, 2025
pulisher
May 13, 2025

Immatics NV earnings missed by €0.07, revenue topped estimates - Investing.com South Africa

May 13, 2025
pulisher
May 13, 2025

Immatics NV reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 13, 2025

IMTX Sees Revenue Decline, Highlights Advances in Melanoma Thera - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Immatics Reports Increased Q1 2025 Loss Amid Rising R&D Costs - TipRanks

May 13, 2025

Finanzdaten der Immatics N V-Aktie (IMTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.00
price up icon 1.52%
$36.00
price down icon 0.06%
$21.32
price down icon 0.15%
$99.07
price down icon 1.72%
$108.80
price up icon 2.21%
biotechnology ONC
$244.86
price up icon 1.07%
Kapitalisierung:     |  Volumen (24h):